Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002231781 | SCV000639805 | uncertain significance | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2017-08-31 | criteria provided, single submitter | clinical testing | In summary, this variant has uncertain impact on FLNA function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with a FLNA-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with asparagine at codon 179 of the FLNA protein (p.Lys179Asn). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and asparagine. |
Laboratory of Inherited Metabolic Diseases, |
RCV002232265 | SCV002512054 | likely pathogenic | Oto-palato-digital syndrome, type II | 2022-04-01 | criteria provided, single submitter | clinical testing |